Health care-associated pneumonia requiring hospital admission: Epidemiology, antibiotic therapy, and clinical outcomes

Archives of Internal Medicine

Volumn 167, Issue 13, 2007, Pages 1393-1399

  Carratalà, Jordi ^a,b   Mykietiuk, Analía ^a   Fernández Sabé, Núria ^a   Suárez, Cristina ^a   Dorca, Jordi ^a   Verdaguer, Ricard ^a   Manresa, Frederic ^a   Gudiol, Francesc ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CLARITHROMYCIN; CLAVULANATE POTASSIUM; ERYTHROMYCIN ETHYLSUCCINATE; LEVOFLOXACIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; EMERGENCY WARD; FATALITY; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; NURSING HOME; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

AGE FACTORS; AGED; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; LEGIONNAIRES' DISEASE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; TRAUMA SEVERITY INDICES;

EID: 34447305472     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.13.1393     Document Type: Article

References (27)

1. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia. Clin Infect Dis. 2000;31(2):347-382.
2. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37(11):1405-1433.
3. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-1754.
4. Fagon JY, Chastre J. Antimicrobial treatment of hospital-acquired pneumonia. Clin Chest Med. 2005;26(1):97-104.
5. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of communityacquired infections. Ann Intern Med. 2002;137(10):791-797.
6. McDonald JR, Friedman D, Stout JE, Sexton DJ, Kaye KS. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med. 2005;165(3):308-313.
7. American Thoracic Society Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
8. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250.
9. Carratalà J, Fernández-Sabé N, Ortega L, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med. 2005;142(3):165-172.
10. Mykietiuk A, Carratalà J, Domínguez A, et al. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 2006;25(7):457-462.
11. Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with communityacquired pneumonia. Arch Intern Med. 2004;164(5):502-508.
12. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Tenth Informational Supplement (Aerobic Dilution). Wayne, PA: National Committee for Clinical Laboratory Standards; 2000. Document M100-S10 (M7).
13. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard Fifth Edition. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000. Document M7-A5; supplemental tables M100-S10.
14. Tablan OC, Anderson JL, Besser R, et al; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia: 2003 recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3):1-36.
15. Craven DE. What is healthcare-associated pneumonia, and how should it be treated? Curr Opin Infect Dis. 2006;19(2):153-160.
16. Fujitani S, Yu VL. A new category - healthcare-associated pneumonia: a good idea, but problems with its execution. Eur J Clin Microbiol Infect Dis. 2006;25(10):627-631.
17. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903.
18. Dorca J, Manresa F, Esteban L, et al. Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumonia. Am J Respir Crit Care Med. 1995;151(5):1491-1496.
19. Sopena N, Sabria M; Neunos 2000 Study Group. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest. 2005;127(1):213-219.
20. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862.
21. Baddour LM, Yu VL, Klugman KP, et al. Combination therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004;170(4):440-444.
22. Pallares R, Gudiol F, Liñares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317(1):18-22.
23. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665-671.
24. Sabria M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis. 2002;2(6):368-373.
25. Rodríguez-Baño J, Navarro MD, Romero L, et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis. 2006;43(11):1407-1414.
26. Peña C, Gudiol C, Tubau F, et al. Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect. 2006;12(3):279-284.
27. Yakovlev SV, Strachounski LS, Woods GL, et al. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit. Eur J Clin Microbiol Infect Dis. 2006;25(10):633-641.